Synthesis and biological evaluation of naphthyldesferrithiocin iron chelators

Journal of Medicinal Chemistry

Volumn 39, Issue 8, 1996, Pages 1575-1581

  Bergeron, Raymond J ^a   Wiegand, Jan ^a   Wollenweber, Markus ^a   McManis, James S ^a   Algee, Samuel E ^a   Ratliff Thompson, Katie ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 HYDROXY 1 NAPHTHYL) 2 THIAZOLINE 4 CARBOXYLIC ACID; 2 (3 HYDROXY 2 NAPHTHYL) 2 THIAZOLINE 4 CARBOXYLIC ACID; CHELATING AGENT; DEFERRIFERRITHIOCIN; IRON CHELATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILE DUCT; BILIARY EXCRETION; CONTROLLED STUDY; DRUG SYNTHESIS; ENANTIOMER; IRON CHELATION; IRON OVERLOAD; KIDNEY CLEARANCE; MALE; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CEBUS; DIHYDROPYRIDINES; IRON; IRON CHELATING AGENTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES;

EID: 0029963339     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9508752     Document Type: Article

References (46)

1. Raymond, K. N.; Carrano, C. J. Coordination Chemistry and Microbial Iron Transport. Acc. Chem. Res. 1979, 12, 183-190.
2. Huebers, H. A.; Finch, C. A. Transferrin: Physiologic Behavior and Clinical Implications. Blood 1984, 64, 763-767.
3. Finch, C. A.; Huebers, H. A. Iron metabolism. Clin. Physiol. Biochem. 1986, 4, 5-10.
4. Hallberg, L. Bioavailability of Dietary Iron in Man. Ann. Rev. Nutr. 1981, 1, 123-147.
5. Finch, C. A.; Huebers, H. Perspectives in Iron Metabolism. N. Engl. J. Med. 1982, 306, 1520-1528.
6. Finch, C. A.; Deubelbeiss, K.; Cook, J. D.; Eschbach, J. W.; Harker, L. A.; Funk, D. D.; Marsaglia, G.; Hillman, R. S.; Slichter, S.; Adamson, J. W.; Ganzoni, A.; Giblett, E. R. Ferrokinetics in Man. Medicine (Baltimore) 1970, 49, 17-53.
7. Seligman, P. A.; Klausner, R. D.; Huebers, H. A. Molecular Mechanisms of Iron Metabolism. In The Molecular Basis of Blood Diseases; Stamatoyannopoulos, G., Nienhuis, A. W., Leder, P., Majerus, P. W., Eds.; W. B. Saunders: Philadelphia, 1987; p 219.
8. O'Connell, M. J.; Ward, R. J.; Baum, H.; Peters, T. J. The Role of Iron in Ferritin- and Haemosiderin-Mediated Lipid Peroxidation in Liposomes. Biochem J. 1985, 229, 135-139.
9. Thomas, C. E.; Morehouse, L. A.; Aust, S. D. Ferritin and Superoxide-Dependent Lipid Peroxidation. J. Biol. Chem. 1985, 260, 3275-3280.
10. Olynyk, J. K.; Bacon, B. R. Hereditary Hemochromatosis. Detecting and Correcting Iron Overload. Postgrad. Med. 1994, 96, 151-165.
11. Erer, B.; Galimberti, M.; Lucarelli, G.; Polchi, P.; Angelucei, E.; Giardini, C.; Baronciani, D.; Tomasucci, M. Bone Marrow Transplantation in Adult Thalassemia. Bone Marrow Transplant. 1993, 12 (S1), 65-66.
12. Keller, J. F.; Blausey, L. A. Diagnosis, Treatment, and Nursing Management of the Patient with Hemochromatosis. Oncol. Nurs. Forum 1992, 19, 1359-1365.
13. Bickel, H.; Hall, G. E.; Keller-Schierlein, W.; Prelog, V.; Vischer, E.; Wettstein, A. Metabolic Products of Actinomycetes, XXVII. Constitutional Formula of Ferrioxamine B. Helv. Chim. Acta 1960, 43, 2129-2138.
14. Aksoy, M.; Seyithanoglu, B. Y.; Bozbora, A. Thalassemia and Desferrioxamine (Desferal) - Introductory Remarks, and Clinical Laboratory Observations. In Hypertension and Iron Chelation in Thalassemia; Aksov, M., Birdwood, G. F. B., Eds.; Berne: Huber, 1984; p 11.
15. Graziano, J. H.; Markenson, A.; Miller, D. R.; Chang, H.; Bestak, M.; Meyers, P.; Pisciotto, P.; Rifkind, A. Chelation Therapy in β-Thalassemia Major. I. Intravenous and Subcutaneous Deferoxamine. J. Pediatr. 1978, 92, 648-652.
16. Pippard, M. J.; Callender, S. T. The Management of Iron Chelation Therapy. Br. J. Haematol. 1983, 54, 503-507.
17. Propper, R. D.; Cooper, B.; Rufo, R. R.; Nienhuis, A. W.; Anderson, W. F.; Bunn, H. F.; Rosenthal, A.; Nathan, D. G. Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload. N. Engl. J. Med. 1977, 297, 418-423.
18. Peter, H. H.; Industrial Aspects of Iron Chelators: Pharmaceutical Applications. In Proteins Iron Storage Transp., Proc. Inter. Conf. Proteins Iron Metab., 7th; Spik, G., Ed.; Elsevier: Amsterdam, The Netherlands, 1985; p 293.
19. Anderegg, G.; L'Eplattenier, F.; Schwarzenbach, G. Hydroxamate Complexes. III. Iron (III) Exchange between Sideramines and Complexones. A Discussion of the Formation Constants of the Hydroxamate Complexes. Helv. Chim. Acta 1963, 46, 1409-1422.
20. Bergeron, R. J.; Streiff, R. R.; Wiegand, J.; Vinson, J. R. T.; Luchetta, G.; Evans, K. M.; Peter, H.; Jenny, H.-B. A Comparative Evaluation of Iron Clearance Models. Ann. N. Y. Acad. Sci. 1990, 612, 378-393.
21. Kirking, M. H. Treatment of Chronic Iron Overload. Clin. Pharmacol. 1991, 10, 775-783.
22. Ponka, P.; Borova, J.; Neuwirt, J.; Fuchs, O. Mobilization of Iron from Reticulocytes. Identification of Pyridoxal Isonicotinoyl Hydrazone as a New Iron Chelating Agent. FEBS Lett. 1979, 97, 317-321.
23. Uhlir, L. C.; Durbin, P. W.; Jeung, N.; Raymond, K. N. Specific Sequestering Agents for the Actinides. 21. Synthesis and Initial Biological Testing of Octadentate Mixed Catecholate-Hydroxypyridinonate Ligands. J. Med. Chem. 1993, 36, 504-509.
24. Kontoghiorghes, G. J.; Aldouri, M. A.; Sheppard, L.; Hoffbrand, A. V. 1,2-Dimethyl-3-hydroxypyrid-4-one, an Orally Active Chelator for Treatment of Iron Overload. Lancet 1987, 1, 1294-1295.
25. Grady, R. W.; Hershko, C. HBED: A Potential Oral Iron Chelator. Ann. N. Y. Acad. Sci. 1990, 612, 361-368.
26. Guterman, S. K.; Morris, P. M.; Tannenberg, W. J. K. Feasibility of Enterochelin as an Iron-Chelating Drug: Studies with Human Serum and a Mouse Model System. Gen. Pharmacol. 1978, 9, 123-127.
27. Grady, R. W.; Peterson, C. M.; Jones, R. L.; Graziano, J. H.; Bhargava, K. K.; Berdoukas, V. A.; Kokkini, G.; Loukopoulos, D.; Cerami, A. Rhodotorulic Acid-Investigation of its Potential as an Iron-Chelating Drug. J. Pharmacol. Exp Ther. 1979, 209, 342-348.
28. Bergeron, R. J. Synthesis and Solution Structure of Microbial Siderophores. Chem. Rev. 1984, 84, 587-602.
29. Bergeron, R. J.; McManis, J. S. Synthesis of Catecholamide and Hydroxamate Siderophores. In Handbook of Microbial Iron Chelates; Winkelmann, G., Ed.; CRC Press: Boca Raton, FL, 1981; pp 271-307.
30. Cox, C. D ; Rinehart, K L., Jr.; Moore, M. L.; Cook, J. C., Jr. Pyochelin: Novel Structure of an Iron-Chelating Growth Promoter for Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 4256-4260.
31. Smith, M. J. Total Synthesis and Absolute Configuration of Rhizobactin. a Structurally Novel Siderophore. Tetrahedron Lett. 1989, 30, 313-316.
32. Naegeli, H.-U.; Zaehner, H. Metabolites of Microorganisms. Part 193. Ferrithiocin. Helv. Chim. Acta 1980, 63, 1400-1406.
33. Anderegg, G.; Raeber, M. Metal Complex Formation of a New Siderophore Desferrithiocin and of Three Related Ligands. J. Chem. Soc., Chem. Commun. 1990, 1194-1196.
34. Longueville, A.; Crichton, R. R. An Animal Model of Iron Overload and its Application to Study Hepatic Ferritin Iron Mobilization by Chelators. Biochem. Pharmacol. 1986, 35, 3669-3678.
35. Wolfe, L. C.; Nicolosi, R. J.; Renaud, M. M.; Finger, J.; Hegsted, M.; Peter, H.; Nathan, D. G. A Non-Human Primate Model for the Study of Oral Iron Chelators. Br. J. Haematol. 1989, 72, 456-461.
36. Bergeron, R. J.; Wiegand, J.; Dionis, J. B.; Egli-Karmakka, M.; Frei, J.; Huxley-Tencer, A.; Peter, H. H. Evaluation of Desferrithiocin and its Synthetic Analogues as Orally Effective Iron Chelators. J. Med. Chem. 1991, 34, 2072-2078.
37. Bergeron, R. J.; Streiff, R. R.; Creary, E. A.; Daniels, R. D., Jr.; King, W.; Luchetta, G.; Wiegand, J.; Moerker, T.; Peter, H. H. A Comparative Study of the Iron-Clearing Properties of Desferrithiocin Analogues with Desferrioxamine B in a Cebus Monkey Model. Blood 1993, 81, 2166-2173.
38. Bergeron, R. J.; Streiff, R. R.; Wiegand, J.; Luchetta, G.; Creary, E. A.; Peter, H. H. A Comparison of the Iron-Clearing Properties of 1,2-Dimethyl-3-hydroxypyrid-4-one, 1,2-Diethyl-3-hydroxypyrid-4-one and Deferoxamine. Blood 1992, 79, 1882-1890.
39. Hahn, F. E.; McMurry, T. J.; Hugi, A.; Raymond, K. N. Coordination Chemistry of Microbial Iron Transport. 42. Structural and Spectroscopic Characterization of Diastereomeric Cr-(III) and Co(III) Complexes of Desferrithiocin. J. Am. Chem. Soc. 1990, 112, 1854-1860.
40. Bergeron, R. J.; Liu, C. Z.; McManis, J. S.; Xia, M. X. B.; Algee, S. E.; Wiegand, J. The Desferrithiocin Pharmacophore. J. Med. Chem. 1994, 37, 1411-1417.
41. Brain, E. G.; Doyle, F. P.; Mehta, M. D.; Miller, D.; Nayler, J. H. C.; Stove, E. R. Derivatives of 6-Aminopenicillanic Acid. Part IV. Analogues of 2,6-Dimethoxyphenylpenicillin in the Naphthalene and Quinoline Series. J. Chem. Soc. 1963, 491-497.
42. Lindgren, B. O.; Nilsson, T. Preparation of Carboxylic Acids from Aldehydes (Including Hydroxylated Benzaldehydes) by Oxidation with Chlorite. Acta Chem. Scand. 1973, 27, 888-890.
43. Bergeron, R. J.; McManis, J. S.; Dionis, J. B.; Garlich, J. R. An Efficient Total Synthesis of Agrobactin and Its Gallium(III) Chelate. J. Org. Chem. 1985, 50, 2780-2782.
44. Job, P. Formation and Stability of Inorganic Complexes in Solution. Ann. Chim. (Paris) 1928, 9, 113-203.
45. Bukata, S.; Marinsky, J. A. Job's Method of Continuous Variations with Ion Exchange for the Study of Complexes in Solution. J. Phys. Chem. 1964, 68, 258-260.
46. Lesser, R ; Kranepuhl, E.; Gad, G. The Constitution of Naphthalenes and their Derivatives. Chem. Ber. 1925, 58, 2109-2124.